GlassScriptPhysician profile
Justin M Mays
NPI 1053796375
$4,504.51
in general payments reported to CMS, 2019-2025
16 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $470 · 2021: $650 · 2022: $444 · 2023: $1,020 · 2024: $569 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913 · Entertainment: $21.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,912.68 |
| Entertainment | $21.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,163.81 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $625.47 | 2019-2025 | Cequa |
| Alcon Vision LLC | $568.90 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Optos, INC. | $196.82 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $174.76 | 2019-2021 | |
| Coopervision INC. | $167.99 | 2019-2023 | Misight Contact Lens, Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $137.51 | 2019-2021 | |
| Allergan, INC. | $125.48 | 2021 | |
| Oyster Point Pharma, INC. | $116.13 | 2022-2024 | Tyrvaya |
| Biotissue Holdings INC. | $103.84 | 2023 | |
| Shire North American Group INC | $39.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.80 | 2021 | |
| Sight Sciences, INC. | $18.74 | 2024 | Tearcare System |
| Bausch & Lomb Americas INC. | $17.42 | 2022 | |
| Lkc Technologies, INC. | $13.75 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Mays listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.